The Risk of SARS-CoV-2 in Immunosuppressed IBD Patients

This is a rapid review of the risk of infection with SARS-CoV-2, the risk of symptomatic cases of COVID-19, and the severity of these cases in IBD patients. Guidance on how to manage IBD patients at risk for infection, and IBD patients after infection is provided. The prevention of infection in both...

Descripción completa

Detalles Bibliográficos
Autores principales: Higgins, Peter D R, Ng, Siew, Danese, Silvio, Rao, Krishna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Hot Topic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184434/
https://www.ncbi.nlm.nih.gov/pubmed/32377636
http://dx.doi.org/10.1093/crocol/otaa026
_version_ 1783526596238376960
author Higgins, Peter D R
Ng, Siew
Danese, Silvio
Rao, Krishna
author_facet Higgins, Peter D R
Ng, Siew
Danese, Silvio
Rao, Krishna
author_sort Higgins, Peter D R
collection PubMed
description This is a rapid review of the risk of infection with SARS-CoV-2, the risk of symptomatic cases of COVID-19, and the severity of these cases in IBD patients. Guidance on how to manage IBD patients at risk for infection, and IBD patients after infection is provided. The prevention of infection in both patients and health care providers by reducing elective visits and procedures, utilizing telemedicine, and social isolation is also emphasized to maintain health care services for IBD patients during a growing pandemic.
format Online
Article
Text
id pubmed-7184434
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-71844342020-04-29 The Risk of SARS-CoV-2 in Immunosuppressed IBD Patients Higgins, Peter D R Ng, Siew Danese, Silvio Rao, Krishna Crohns Colitis 360 Hot Topic Review This is a rapid review of the risk of infection with SARS-CoV-2, the risk of symptomatic cases of COVID-19, and the severity of these cases in IBD patients. Guidance on how to manage IBD patients at risk for infection, and IBD patients after infection is provided. The prevention of infection in both patients and health care providers by reducing elective visits and procedures, utilizing telemedicine, and social isolation is also emphasized to maintain health care services for IBD patients during a growing pandemic. Oxford University Press 2020-04-16 /pmc/articles/PMC7184434/ /pubmed/32377636 http://dx.doi.org/10.1093/crocol/otaa026 Text en © 2020 Crohn’s & Colitis Foundation. Published by Oxford University Press on behalf of Crohn's & Colitis Foundation. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Hot Topic Review
Higgins, Peter D R
Ng, Siew
Danese, Silvio
Rao, Krishna
The Risk of SARS-CoV-2 in Immunosuppressed IBD Patients
title The Risk of SARS-CoV-2 in Immunosuppressed IBD Patients
title_full The Risk of SARS-CoV-2 in Immunosuppressed IBD Patients
title_fullStr The Risk of SARS-CoV-2 in Immunosuppressed IBD Patients
title_full_unstemmed The Risk of SARS-CoV-2 in Immunosuppressed IBD Patients
title_short The Risk of SARS-CoV-2 in Immunosuppressed IBD Patients
title_sort risk of sars-cov-2 in immunosuppressed ibd patients
topic Hot Topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184434/
https://www.ncbi.nlm.nih.gov/pubmed/32377636
http://dx.doi.org/10.1093/crocol/otaa026
work_keys_str_mv AT higginspeterdr theriskofsarscov2inimmunosuppressedibdpatients
AT ngsiew theriskofsarscov2inimmunosuppressedibdpatients
AT danesesilvio theriskofsarscov2inimmunosuppressedibdpatients
AT raokrishna theriskofsarscov2inimmunosuppressedibdpatients
AT higginspeterdr riskofsarscov2inimmunosuppressedibdpatients
AT ngsiew riskofsarscov2inimmunosuppressedibdpatients
AT danesesilvio riskofsarscov2inimmunosuppressedibdpatients
AT raokrishna riskofsarscov2inimmunosuppressedibdpatients

Ejemplares similares